Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus
Open Access
- 1 November 1997
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 176 (5) , 1215-1224
- https://doi.org/10.1086/514115
Abstract
Neutralizing polyclonal antibody to respiratory syncytial virus (RSV) has been shown to be an effective prophylactic agent when administered intravenKeywords
This publication has 0 references indexed in Scilit: